Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 163

1.
2.

Flat Epithelial Atypia in Breast Core Needle Biopsies With Radiologic-Pathologic Concordance: Is Excision Necessary?

Grabenstetter A, Brennan S, Salagean ED, Morrow M, Brogi E.

Am J Surg Pathol. 2019 Oct 11. doi: 10.1097/PAS.0000000000001385. [Epub ahead of print]

PMID:
31609784
3.

Ultrasound- versus landmark-guided subclavian vein catheterization: a prospective observational study from a tertiary referral hospital.

Sidoti A, Brogi E, Biancofiore G, Casagli S, Guarracino F, Malacarne P, Tollapi L, Borselli M, Santori G, Corradi F, Forfori F.

Sci Rep. 2019 Aug 22;9(1):12248. doi: 10.1038/s41598-019-48766-1.

4.

Clinical-grade computational pathology using weakly supervised deep learning on whole slide images.

Campanella G, Hanna MG, Geneslaw L, Miraflor A, Werneck Krauss Silva V, Busam KJ, Brogi E, Reuter VE, Klimstra DS, Fuchs TJ.

Nat Med. 2019 Aug;25(8):1301-1309. doi: 10.1038/s41591-019-0508-1. Epub 2019 Jul 15.

PMID:
31308507
5.

Impact of biomarkers and genetic profiling on breast cancer prognostication: A comparative analysis of the 8th edition of breast cancer staging system.

Yoon EC, Schwartz C, Brogi E, Ventura K, Wen H, Darvishian F.

Breast J. 2019 Sep;25(5):829-837. doi: 10.1111/tbj.13352. Epub 2019 Jun 13.

PMID:
31197914
6.

Atrial Fibrillation in Patients with Septic Shock: A One-Year Observational Pilot Study.

Steinberg I, Brogi E, Pratali L, Trunfio D, Giuliano G, Bignami E, Forfori F.

Turk J Anaesthesiol Reanim. 2019 Jun;47(3):213-219. doi: 10.5152/TJAR.2019.44789. Epub 2019 Jan 24.

7.

Is Sentinel Lymph Node Biopsy Required for a Core Biopsy Diagnosis of Ductal Carcinoma In Situ with Microinvasion?

Flanagan MR, Stempel M, Brogi E, Morrow M, Cody HS 3rd.

Ann Surg Oncol. 2019 Sep;26(9):2738-2746. doi: 10.1245/s10434-019-07475-9. Epub 2019 May 30.

PMID:
31147995
8.

Pathologic complete response rate according to HER2 detection methods in HER2-positive breast cancer treated with neoadjuvant systemic therapy.

Krystel-Whittemore M, Xu J, Brogi E, Ventura K, Patil S, Ross DS, Dang C, Robson M, Norton L, Morrow M, Wen HY.

Breast Cancer Res Treat. 2019 Aug;177(1):61-66. doi: 10.1007/s10549-019-05295-9. Epub 2019 May 29.

PMID:
31144151
9.

Normothermic Regional Perfusion for Controlled Donation After Circulatory Death: A Technical Complication During Normothermic Regional Perfusion.

Brogi E, Circelli A, Gamberini E, Russo E, Benni M, Pizzilli G, Agnoletti V.

ASAIO J. 2019 Feb 7. doi: 10.1097/MAT.0000000000000963. [Epub ahead of print]

PMID:
31085950
10.

Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.

Sambade MJ, Prince G, Deal AM, Trembath D, McKee M, Garrett A, Keith K, Ramirez J, Midkiff B, Blackwell K, Sammons S, Leone JP, Brufsky A, Morikawa A, Brogi E, Seidman A, Ewend M, Carey LA, Moschos SJ, Hamilton RL, Vincent B, Anders C.

Breast Cancer Res Treat. 2019 Jul;176(2):321-328. doi: 10.1007/s10549-019-05211-1. Epub 2019 Apr 23.

PMID:
31016641
11.

Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasising distant metastatic potential.

Hoda RS, Brogi E, Pareja F, Nanjangud G, Murray MP, Weigelt B, Reis-Filho JS, Wen HY.

Histopathology. 2019 Aug;75(2):213-224. doi: 10.1111/his.13879. Epub 2019 Jul 10.

PMID:
31012486
12.

Flura-seq identifies organ-specific metabolic adaptations during early metastatic colonization.

Basnet H, Tian L, Ganesh K, Huang YH, Macalinao DG, Brogi E, Finley LW, Massagué J.

Elife. 2019 Mar 26;8. pii: e43627. doi: 10.7554/eLife.43627.

13.

Micropapillary variant of mucinous carcinoma of the breast shows genetic alterations intermediate between those of mucinous carcinoma and micropapillary carcinoma.

Pareja F, Selenica P, Brown DN, Sebastiao APM, da Silva EM, Da Cruz Paula A, Del A, Fu L, Weigelt B, Brogi E, Reis-Filho JS, Wen HY.

Histopathology. 2019 Jul;75(1):139-145. doi: 10.1111/his.13853. Epub 2019 Jun 13.

PMID:
30843622
14.

Sugammadex for reversal of neuromuscular blockade in paediatric patients: A two-year single-centre retrospective study.

Simonini A, Brogi E, Calevo MG, Carron M.

Anaesth Crit Care Pain Med. 2019 Oct;38(5):529-531. doi: 10.1016/j.accpm.2019.02.010. Epub 2019 Feb 25. No abstract available.

PMID:
30818070
15.

Assessment of HMGA2 and PLAG1 rearrangements in breast adenomyoepitheliomas.

Pareja F, Geyer FC, Brown DN, Sebastião APM, Gularte-Mérida R, Li A, Edelweiss M, Da Cruz Paula A, Selenica P, Wen HY, Jungbluth AA, Varga Z, Palazzo J, Rubin BP, Ellis IO, Brogi E, Rakha EA, Weigelt B, Reis-Filho JS.

NPJ Breast Cancer. 2019 Jan 18;5:6. doi: 10.1038/s41523-018-0101-7. eCollection 2019.

16.

The Genomic Landscape of Mucinous Breast Cancer.

Pareja F, Lee JY, Brown DN, Piscuoglio S, Gularte-Mérida R, Selenica P, Da Cruz Paula A, Arunachalam S, Kumar R, Geyer FC, Silveira C, da Silva EM, Li A, Marchiò C, Ng CKY, Mariani O, Fuhrmann L, Wen HY, Norton L, Vincent-Salomon A, Brogi E, Reis-Filho JS, Weigelt B.

J Natl Cancer Inst. 2019 Jan 11. doi: 10.1093/jnci/djy216. [Epub ahead of print]

PMID:
30649385
17.

Author Correction: Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.

Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J.

Nat Cell Biol. 2019 Mar;21(3):408. doi: 10.1038/s41556-018-0257-2.

PMID:
30542103
18.

Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway.

Li Z, Razavi P, Li Q, Toy W, Liu B, Ping C, Hsieh W, Sanchez-Vega F, Brown DN, Da Cruz Paula AF, Morris L, Selenica P, Eichenberger E, Shen R, Schultz N, Rosen N, Scaltriti M, Brogi E, Baselga J, Reis-Filho JS, Chandarlapaty S.

Cancer Cell. 2018 Dec 10;34(6):893-905.e8. doi: 10.1016/j.ccell.2018.11.006.

PMID:
30537512
19.

Recurrent MED12 exon 2 mutations in benign breast fibroepithelial lesions in adolescents and young adults.

Pareja F, Da Cruz Paula A, Murray MP, Hoang T, Gularte-Mérida R, Brown D, da Silva EM, Sebastiao APM, Giri DD, Weigelt B, Reis-Filho JS, Brogi E.

J Clin Pathol. 2019 Mar;72(3):258-262. doi: 10.1136/jclinpath-2018-205570. Epub 2018 Nov 22.

20.

Reply to "Multicentric Ipsilateral Invasive Breast Carcinomas Might Have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas".

Grabenstetter A, Brogi E, Chou J, Morrow M, Dickler M, Norton L, Wen H.

Ann Surg Oncol. 2019 Jan;26(1):310-311. doi: 10.1245/s10434-018-7078-1. Epub 2018 Nov 19. No abstract available.

PMID:
30456683
21.

Multifocal/Multicentric Ipsilateral Invasive Breast Carcinomas with Similar Histology: Is Multigene Testing of All Individual Foci Necessary?

Grabenstetter A, Brogi E, Chou JF, Morrow M, Dickler M, Norton L, Wen HY.

Ann Surg Oncol. 2019 Feb;26(2):329-335. doi: 10.1245/s10434-018-6866-y. Epub 2018 Oct 8.

PMID:
30298311
22.

Anaphylactic Shock During Pediatric Anesthesia: An Unexpected Reaction to Sevoflurane.

Simonini A, Brogi E, Gily B, Tosca M, Barbieri C, Antonini F, Del Zotto G.

Front Pediatr. 2018 Sep 7;6:236. doi: 10.3389/fped.2018.00236. eCollection 2018.

23.

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers.

Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, Cai Y, Bielski CM, Donoghue MTA, Jonsson P, Penson A, Shen R, Pareja F, Kundra R, Middha S, Cheng ML, Zehir A, Kandoth C, Patel R, Huberman K, Smyth LM, Jhaveri K, Modi S, Traina TA, Dang C, Zhang W, Weigelt B, Li BT, Ladanyi M, Hyman DM, Schultz N, Robson ME, Hudis C, Brogi E, Viale A, Norton L, Dickler MN, Berger MF, Iacobuzio-Donahue CA, Chandarlapaty S, Scaltriti M, Reis-Filho JS, Solit DB, Taylor BS, Baselga J.

Cancer Cell. 2018 Sep 10;34(3):427-438.e6. doi: 10.1016/j.ccell.2018.08.008.

24.

Immunohistochemical analysis of estrogen receptor in breast cancer with ESR1 mutations detected by hybrid capture-based next-generation sequencing.

Ross DS, Zehir A, Brogi E, Konno F, Krystel-Whittemore M, Edelweiss M, Berger MF, Toy W, Chandarlapaty S, Razavi P, Baselga J, Wen HY.

Mod Pathol. 2019 Jan;32(1):81-87. doi: 10.1038/s41379-018-0116-5. Epub 2018 Aug 29.

PMID:
30158597
25.

Novel Orthopoxvirus and Lethal Disease in Cat, Italy.

Lanave G, Dowgier G, Decaro N, Albanese F, Brogi E, Parisi A, Losurdo M, Lavazza A, Martella V, Buonavoglia C, Elia G.

Emerg Infect Dis. 2018 Sep;24(9):1665-1673. doi: 10.3201/eid2409.171283.

26.

Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization.

Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, Griscom B, Rosenblum M, Boire A, Brogi E, Giancotti FG, Schachner M, Malladi S, Massagué J.

Nat Cell Biol. 2018 Aug;20(8):966-978. doi: 10.1038/s41556-018-0138-8. Epub 2018 Jul 23. Erratum in: Nat Cell Biol. 2019 Mar;21(3):408.

27.

Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas.

Geyer FC, Li A, Papanastasiou AD, Smith A, Selenica P, Burke KA, Edelweiss M, Wen HC, Piscuoglio S, Schultheis AM, Martelotto LG, Pareja F, Kumar R, Brandes A, Fan D, Basili T, Da Cruz Paula A, Lozada JR, Blecua P, Muenst S, Jungbluth AA, Foschini MP, Wen HY, Brogi E, Palazzo J, Rubin BP, Ng CKY, Norton L, Varga Z, Ellis IO, Rakha EA, Chandarlapaty S, Weigelt B, Reis-Filho JS.

Nat Commun. 2018 May 8;9(1):1816. doi: 10.1038/s41467-018-04128-5.

28.

Solid papillary breast carcinomas resembling the tall cell variant of papillary thyroid neoplasms (solid papillary carcinomas with reverse polarity) harbour recurrent mutations affecting IDH2 and PIK3CA: a validation cohort.

Lozada JR, Basili T, Pareja F, Alemar B, Paula ADC, Gularte-Merida R, Giri DD, Querzoli P, Cserni G, Rakha EA, Foschini MP, Reis-Filho JS, Brogi E, Weigelt B, Geyer FC.

Histopathology. 2018 Aug;73(2):339-344. doi: 10.1111/his.13522. Epub 2018 Jun 1.

29.

Regional citrate-calcium anticoagulation during polymyxin-B hemoperfusion: A case series.

Forfori F, Brogi E, Sidoti A, Giraudini M, Monti G, Zarrillo N, Cantaluppi V, Ronco C.

Int J Artif Organs. 2018 Jun;41(6):319-324. doi: 10.1177/0391398818762360. Epub 2018 Mar 26.

30.

The 21-Gene Recurrence Score in Male Breast Cancer.

Turashvili G, Gonzalez-Loperena M, Brogi E, Dickler M, Norton L, Morrow M, Wen HY.

Ann Surg Oncol. 2018 Jun;25(6):1530-1535. doi: 10.1245/s10434-018-6411-z. Epub 2018 Mar 8.

31.

"A Message in the Bottle".

Vetrugno L, Brogi E, Barbariol F, Forfori F, Bignami E.

Anesthesiology. 2018 Mar;128(3):677. doi: 10.1097/ALN.0000000000002039. No abstract available.

PMID:
29438245
32.

Lobular Carcinoma In Situ.

Wen HY, Brogi E.

Surg Pathol Clin. 2018 Mar;11(1):123-145. doi: 10.1016/j.path.2017.09.009. Epub 2017 Dec 8. Review.

33.

Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.

Turashvili G, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY.

BMC Cancer. 2018 Jan 6;18(1):42. doi: 10.1186/s12885-017-3985-y.

34.

Thoracic ultrasound for pleural effusion in the intensive care unit: a narrative review from diagnosis to treatment.

Brogi E, Gargani L, Bignami E, Barbariol F, Marra A, Forfori F, Vetrugno L.

Crit Care. 2017 Dec 28;21(1):325. doi: 10.1186/s13054-017-1897-5. Review.

35.

Tumor Heterogeneity in Breast Cancer.

Turashvili G, Brogi E.

Front Med (Lausanne). 2017 Dec 8;4:227. doi: 10.3389/fmed.2017.00227. eCollection 2017. Review.

36.

Phyllodes tumors with and without fibroadenoma-like areas display distinct genomic features and may evolve through distinct pathways.

Pareja F, Geyer FC, Kumar R, Selenica P, Piscuoglio S, Ng CKY, Burke KA, Edelweiss M, Murray MP, Brogi E, Weigelt B, Reis-Filho JS.

NPJ Breast Cancer. 2017 Oct 12;3:40. doi: 10.1038/s41523-017-0042-6. eCollection 2017.

37.

Lung Ultrasonography as the First Confirmation Method for Central Venous Catheterization: How Far Are We?

Brogi E, Bignami E, Vetrugno L, Forfori F.

Crit Care Med. 2017 Nov;45(11):e1189-e1190. doi: 10.1097/CCM.0000000000002598. No abstract available.

PMID:
29028713
38.

Monosomy 17 in potentially curable HER2-amplified breast cancer: prognostic and predictive impact.

Page DB, Wen H, Brogi E, Dure D, Ross D, Spinelli KJ, Patil S, Norton L, Hudis C, McArthur HL.

Breast Cancer Res Treat. 2018 Jan;167(2):547-554. doi: 10.1007/s10549-017-4520-1. Epub 2017 Oct 6.

PMID:
28986743
39.

Could the use of bedside lung ultrasound reduce the number of chest x-rays in the intensive care unit?

Brogi E, Bignami E, Sidoti A, Shawar M, Gargani L, Vetrugno L, Volpicelli G, Forfori F.

Cardiovasc Ultrasound. 2017 Sep 13;15(1):23. doi: 10.1186/s12947-017-0113-8.

40.

Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor.

Piscuoglio S, Geyer FC, Burke KA, Murray MP, Ng CK, Mota A, Marchio C, Berman SH, Norton L, Brogi E, Weigelt B, Reis-Filho JS.

NPJ Breast Cancer. 2016 Nov 16;2:16035. doi: 10.1038/npjbcancer.2016.35. eCollection 2016.

41.

21-Gene recurrence score and locoregional recurrence in lymph node-negative, estrogen receptor-positive breast cancer.

Turashvili G, Chou JF, Brogi E, Morrow M, Dickler M, Norton L, Hudis C, Wen HY.

Breast Cancer Res Treat. 2017 Nov;166(1):69-76. doi: 10.1007/s10549-017-4381-7. Epub 2017 Jul 12.

42.

Benign vascular lesions of the breast diagnosed by core needle biopsy do not require excision.

Sebastiano C, Gennaro L, Brogi E, Morris E, Bowser ZL, Antonescu CR, Pareja F, Brennan S, Murray MP.

Histopathology. 2017 Nov;71(5):795-804. doi: 10.1111/his.13291. Epub 2017 Sep 8.

43.

Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.

De Brot M, Koslow Mautner S, Muhsen S, Andrade VP, Mamtani A, Murray M, Giri D, Sakr RA, Brogi E, King TA.

Breast Cancer Res Treat. 2017 Sep;165(2):411-420. doi: 10.1007/s10549-017-4334-1. Epub 2017 Jun 13.

44.

The 21-gene recurrence score in special histologic subtypes of breast cancer with favorable prognosis.

Turashvili G, Brogi E, Morrow M, Hudis C, Dickler M, Norton L, Wen HY.

Breast Cancer Res Treat. 2017 Aug;165(1):65-76. doi: 10.1007/s10549-017-4326-1. Epub 2017 Jun 3.

45.

Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study.

Lozada JR, Burke KA, Maguire A, Pareja F, Lim RS, Kim J, Gularte-Merida R, Murray MP, Brogi E, Weigelt B, Reis-Filho JS, Geyer FC.

Histopathology. 2017 Oct;71(4):626-634. doi: 10.1111/his.13258. Epub 2017 Jul 5.

46.

Fibroepithelial Lesions in the Breast of Adolescent Females: A Clinicopathological Study of 54 Cases.

Ross DS, Giri DD, Akram MM, Catalano JP, Olcese C, Van Zee KJ, Brogi E.

Breast J. 2017 Mar;23(2):182-192. doi: 10.1111/tbj.12706. Epub 2016 Nov 4.

47.

Specimen Identification Errors in Breast Biopsies: Age Matters. Report of Two Near-Miss Events and Review of the Literature.

Tozbikian G, Gemignani ML, Brogi E.

Breast J. 2017 Sep;23(5):583-588. doi: 10.1111/tbj.12797. Epub 2017 Mar 16.

48.

Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.

Mutter RW, Riaz N, Ng CK, Delsite R, Piscuoglio S, Edelweiss M, Martelotto LG, Sakr RA, King TA, Giri DD, Drobnjak M, Brogi E, Bindra R, Bernheim G, Lim RS, Blecua P, Desrichard A, Higginson D, Towers R, Jiang R, Lee W, Weigelt B, Reis-Filho JS, Powell SN.

J Pathol. 2017 Jun;242(2):165-177. doi: 10.1002/path.4890. Epub 2017 Apr 27.

49.

Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.

Geyer FC, Burke KA, Piscuoglio S, Ng CKY, Papanastasiou AD, Marchiò C, Selenica P, Edelweiss M, Murray MP, Brogi E, Soslow RA, Rubin BP, Norton L, Reis-Filho JS, Weigelt B.

Mol Oncol. 2017 Aug;11(8):913-926. doi: 10.1002/1878-0261.12049. Epub 2017 May 16.

50.

Response to: Influence of Mechanical Mentilation on the Incidence of Pneumothorax During Infraclavicular Subclavian Vein Catheterization: A Prospective Randomized Noninferiority Trial.

Brogi E, Martinelli G, Forfori F.

Anesth Analg. 2017 Mar;124(3):1015-1016. doi: 10.1213/ANE.0000000000001862. No abstract available.

PMID:
28207458

Supplemental Content

Support Center